Halyard Health’s Indian subsidiary divests surgical business

0
2246
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

Halyard Health, a global supplier of medical devices and solutions, is selling its Indian subsidiary’s Surgical and Infection Prevention (S&IP) business division to Owens & Minor for ₹45 billion (US$710 million).

The transaction confirms investor appetite and growing opportunities in India’s healthcare sector. “With a population that is soon going to exceed China’s, India’s healthcare needs are burgeoning,” said Akil Hirani, the managing partner at Majmudar & Partners, who led a team advising Halyard on Indian law matters. “Hospital chains, diagnostic clinics, life sciences companies doing drug discovery, and medical devices firms are seeing a huge potential and are being aggressively pursued by strategic and financial investors.”

S&IP provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. Its portfolio of surgical and infection prevention offerings includes sterilization wraps, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link